The high expression of exo-AnxA2 levels in serum samples of AA TNBC patients and its association with tumor grades are consistent with our previous studies showing that the high expression of AnxA2 mRNA in tumor tissues of different breast cancer subtypes is significantly associated with the progression of TNBC and AA TNBC patients [30]. The gene discussed is ANXA2; the disease is breast carcinoma.